Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of the American College of Cardiology

• Publication date

  2003-05-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0735-1097(03)00189-XPMID 12742298
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hypertrophic Cardiomyopathy: Histopathological Features of Sudden Death in Cardiac Troponin T Disease

  2001cited by this paper
• Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy.

  2001cited by this paper
• The molecular genetic basis for hypertrophic cardiomyopathy.

  2001cited by this paper
• Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy.

  2001cited by this paper
• Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction.

  2001cited by this paper
• Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction.

  2001cited by this paper
• An improved MR imaging technique for the visualization of myocardial infarction.

  2001cited by this paper
• Sudden death in hypertrophic cardiomyopathy.

  2000cited by this paper
• Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease

  2000cited by this paper
• The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.

  2000cited by this paper
• Sudden death in hypertrophic cardiomyopathy: identification of high risk patients.

  2000cited by this paper
• Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy.

  2000cited by this paper
• Predictors of death from congestive heart failure in hypertrophic cardiomyopathy.

  1999cited by this paper
• The management of hypertrophic cardiomyopathy.

  1997cited by this paper
• Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction.

  1996cited by this paper
• Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

  1996cited by this paper
• Natural history of hypertrophic cardiomyopathy. A population-based study, 1976 through 1990.

  1995cited by this paper
• Efficacy of a new calcium antagonist PN 200-110 (isradipine) in angina pectoris.

  1987cited by this paper
• Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy.

  1987cited by this paper
• Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy.

  1986cited by this paper
• Coronary artery disease in hypertrophic cardiomyopathy.

  1985cited by this paper
• The current status of myocardial disarray in hypertrophic cardiomyopathy.

  1984cited by this paper
• Histopathological specificity of hypertrophic obstructive cardiomyopathy. Myocardial fibre disarray and myocardial fibrosis.

  1980cited by this paper
• Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries.

  1979cited by this paper
• Idiopathic Hypertrophic Subaortic Stenosis: Clinical Analysis of 126 Patients with Emphasis on the Natural History

  1968cited by this paper

• Prognostic value of CMR-derived myocardial strain in hypertrophic cardiomyopathy: a systematic review and meta-analysis.

  2026cites this paper
• 2-[18F]FDG PET identifies metabolic substrates of sudden cardiac death in hypertrophic cardiomyopathy

  2025cites this paper
• Apical Hypertrophic Cardiomyopathy: A Rare and Hidden Cause of Stroke

  2025cites this paper
• A Hidden Diagnosis Behind Giant Inverted T-waves: Recognizing Apical Hypertrophic Cardiomyopathy in a Young Adult

  2025cites this paper
• The relationship between serum Lumican levels and myocardial fibrosis in patients with hypertrophic cardiomyopathy.

  2025cites this paper
• Scar Architecture as a Structural Biomarker of Ventricular Arrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy: a Cardiac Magnetic Resonance Study.

  2025cites this paper
• Advancing Cardiovascular Diagnostics: The Expanding Role of CMR in Heart Failure and Cardiomyopathies

  2025cites this paper
• Prognostic value of late gadolinium enhancement on cardiac magnetic resonance imaging for non-sustained ventricular tachycardia and sudden cardiac death in hypertrophic cardiomyopathy: a meta-analysis

  2025cites this paper
• Sudden Death Risk Assessment in Hypertrophic Cardiomyopathy Across the Lifespan: Reconciling the American and European Approaches.

  2025cites this paper
• Not all that thickens is hypertrophic cardiomyopathy: a case report of unusual Takotsubo cardiomyopathy

  2025cites this paper
• 2-[18F]FDG PET/CT identifies metabolic activity linked to myocardial deformation in hypertrophic cardiomyopathy

  2025cites this paper
• Phenotypic Spectrum of Subclinical Sarcomere-Related Hypertrophic Cardiomyopathy and Transition to Overt Disease

  2024cites this paper
• Myocardial Fibrosis Quantification Methods by Cardiovascular Magnetic Resonance Imaging in Patients with Fabry Disease

  2024cites this paper
• Focal ischemic myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy

  2024cites this paper
• Revealing the unrevealed: echocardiography for non-ischemic scar tissue detection.

  2024cites this paper
• Subendocardial Involvement as an Underrecognized LGE Subtype Related to Adverse Outcomes in Hypertrophic Cardiomyopathy.

  2023cites this paper
• Tale of two hearts: a TNNT2 hypertrophic cardiomyopathy case report

  2023cites this paper
• Multimodality Imaging in Sarcomeric Hypertrophic Cardiomyopathy: Get It Right…on Time

  2023cites this paper
• Sudden Death Risk Assessment in Hypertrophic Cardiomyopathy Across the Lifespan: Reconciling the American and European Approaches.

  2023cites this paper
• Late gadolinium enhancement entropy as a new measure of myocardial tissue heterogeneity for prediction of adverse cardiac events in patients with hypertrophic cardiomyopathy

  2023cites this paper
• Hypertrophic Cardiomyopathy: A Review Using Magnetic Resonance Imaging

  2022cites this paper
• Detecting Regional Fibrosis in Hypertrophic Cardiomyopathy: The Utility of Myocardial Strain Based on Cardiac Magnetic Resonance.

  2022cites this paper
• Cardiac Hypertrophy and Related Dysfunctions in Cushing Syndrome Patients—Literature Review

  2022cites this paper
• How to Perform a Diagnostic and Prognostic Analysis of Hypertrophic Cardiomyopathy in 2022: Should we Divide to Improve Treatment? DIC-SBC Women’s Group Difficulty Introducing Contrast Echocardiography in Daily Clinical Practice in South America: A Matter of Economy?

  2022cites this paper
• The Role of Cardiovascular Magnetic Resonance Imaging in the Evaluation of Hypertrophic Cardiomyopathy

  2022cites this paper
• Remodelling of potassium currents underlies arrhythmic action potential prolongation under beta-adrenergic stimulation in hypertrophic cardiomyopathy

  2022cites this paper
• Hypertrophic Cardiomyopathy in Pregnancy.

  2021cites this paper
• The Clinical Prognosis of Presence and Location of Late Gadolinium Enhancement by Cardiac Magnetic Resonance Imaging in Patients with Hypertrophic Cardiomyopathy: a Single-Center Cohort Study

  2021cites this paper
• Epidemio-Clinical and MRI Aspects of Cardiac Pathologies in Sub-Saharan Africa, About 70 Cases

  2021cites this paper
• Cardiovascular Magnetic Resonance (CMR) for the Evaluation of Myocardial Infarction in Patients with Non-obstructive Coronary Artery Disease (MINOCA)

  2021cites this paper
• Machine learning phenotyping of scarred myocardium from cine in hypertrophic cardiomyopathy.

  2021cites this paper
• High ECG Risk-Scores Predict Late Gadolinium Enhancement on Magnetic Resonance Imaging in HCM in the Young

  2021cites this paper
• Evaluation of Diastolic Function by Cardiac Magnetic Resonance Imaging

  2021cites this paper
• Optimal Contrast-Enhanced Computed Tomography and Magnetic Resonance Cardiac Imaging

  2021cites this paper
• Effectiveness of alcohol septal ablation for hypertrophic obstructive cardiomyopathy in patients with late gadolinium enhancement on cardiac magnetic resonance.

  2020cites this paper
• Updating the Risk Stratification for Sudden Cardiac Death in Cardiomyopathies: The Evolving Role of Cardiac Magnetic Resonance Imaging. An Approach for the Electrophysiologist

  2020cites this paper
• What is the mid-wall linear high intensity “lesion” on cardiovascular magnetic resonance late gadolinium enhancement?

  2020cites this paper
• Late Gadolinium Enhancement–Dispersion Mapping

  2020cites this paper
• Prevalence and clinical significance of cardiovascular magnetic resonance adenosine stress-induced myocardial perfusion defect in hypertrophic cardiomyopathy

  2020cites this paper
• Cardiovascular complications of acromegaly.

  2020cites this paper
• Cardiac MRI: technical basis

  2020cites this paper
• Differentiating Athlete’s Heart from Left Ventricle Cardiomyopathies

  2020cites this paper
• Risk stratification using late gadolinium enhancement on cardiac magnetic resonance imaging in patients with hypertrophic cardiomyopathy: A systematic review and meta-analysis.

  2020cites this paper
• Long-Term Performance of Right Ventricular Implantable Cardioverter-Defibrillator Leads in Arrhythmogenic Right Ventricular Cardiomyopathy and Hypertrophic Cardiomyopathy.

  2020cites this paper
• Magnetic Resonance Imaging Assessment of Pre- and Post-Surgery Myocardial Changes in Hypertrophic Cardiomyopathy: Correlation with Echocardiography

  2020cites this paper
• Quantification of right ventricular extracellular volume in pulmonary hypertension using cardiac magnetic resonance imaging.

  2020cites this paper
• Cardiac Noninvasive Imaging: Chest Radiography, Cardiovascular Magnetic Resonance and Computed Tomography of the Heart

  2020cites this paper
• The feasibility and diagnostic value of intravoxel incoherent motion diffusion-weighted imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy patients.

  2020cites this paper
• Cardiac Imaging in the Athlete: Shrinking the “Gray Zone”

  2020cites this paper
• Hypertrophic cardiomyopathy

  2020cites this paper
• Rarely seen primary cardiac natural killer/T cell lymphoma: a case report

  2020cites this paper
• The use of contrast‐enhanced transthoracic echocardiography for spiral‐variant hypertrophic cardiomyopathy

  2020cites this paper
• Elevation of high‐sensitivity cardiac troponin T and left ventricular remodelling in hypertrophic cardiomyopathy

  2020cites this paper
• Copyright and Disclaimer

  2019cites this paper
• Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy

  2019cites this paper
• Prognostic significance of left ventricular end diastolic pressure using E/E' in patients with hypertrophic cardiomyopathy

  2019cites this paper
• Defining genotype-phenotype relationships in patients with hypertrophic cardiomyopathy using cardiovascular magnetic resonance imaging

  2019cites this paper
• Role of Cardiac Magnetic Resonance Imaging and Late Gadolinium Enhancement in Relation to Arrhythmias in Different Cardiomyopathies

  2019cites this paper
• Diagnóstico y estudio de cardiopatías infrecuentes: multimodalidad – miocardiopatía hipertrófica

  2019cites this paper
• Kobe University Repository : Kernel タイトル Tit le Myocardial Impairment Detected by Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy : Comparison with 99 mTc-MIBI / Tetrofosmin and 123 I-BMIPP SPECT 著者

  2019cites this paper
• Die diastolisch-systolische Auslenkungsstrecke des Mitralklappenanulus (MAPSE) als eineinfaches diagnostisches Mittel zur Detektierung einer Fibrose mittels kardiologischer Magnetresonanztomographie mit Late Gadolinium Enhancement - Darstellung bei Patientenmit hypertropher Kardiomyopathie

  2019cites this paper
• Imaging-Specific Cardiomyopathies: A Practical Guide.

  2019cites this paper
• Assessment of Cardiomyopathies and Cardiac Transplantation

  2019cites this paper
• Programmed Ventricular Stimulation in the Management of Brugada Syndrome Patients

  2019cites this paper
• Myocardial Fibrosis in Hypertrophic Cardiomyopathy: What Remains to be Proven?

  2019cites this paper
• Influence of centre expertise on the diagnosis and management of hypertrophic cardiomyopathy: A study from the French register of hypertrophic cardiomyopathy (REMY).

  2019cites this paper
• Advances in cardiovascular imaging

  2019cites this paper
• Microvascular Dysfunction in Hypertrophic Cardiomyopathy

  2019cites this paper
• 61 – Hypertrophic Cardiomyopathy

  2018cites this paper
• A case report of apical aneurysms and myocardial perfusion deficit with myocardial necrosis due to hypertrophic cardiomyopathy

  2018cites this paper
• Cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy: the importance of clinical context

  2018cites this paper
• AL Cardiac Amyloidosis: Classification, Diagnosis, and Treatment

  2018cites this paper
• 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.

  2018cites this paper
• 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

  2018cites this paper
• Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy

  2018cites this paper
• Cardiac MR Imaging of Hypertrophic Cardiomyopathy: Techniques, Findings, and Clinical Relevance

  2018cites this paper
• Comparison of quantitative imaging parameters using cardiovascular magnetic resonance between cardiac amyloidosis and hypertrophic cardiomyopathy: inversion time scout versus T1 mapping

  2018cites this paper
• Evaluation of Galectin-3 and Myocardial Fibrosis in Patients with Hypertrophic Cardiomyopathy

  2018cites this paper
• Clinical applications of multiparametric CMR in left ventricular hypertrophy

  2018cites this paper
• Correlation of Electrocardiographic Changes with Cardiac Magnetic Resonance Findings in Patients with Hypertrophic Cardiomyopathy

  2018cites this paper
• Value of the Electrocardiographic (P Wave, T Wave, QRS) Axis as a Predictor of Mortality in 14 Years in a Population With a High Prevalence of Chagas Disease from the Bambuí Cohort Study of Aging.

  2018cites this paper
• The Imaging of Myocardial Scars on MRI: The Role of a Radiologist

  2018cites this paper
• Cardiovascular Genetics and Genomics

  2018cites this paper
• Approach to the Initial and Follow-Up Visits

  2018cites this paper
• Inherited Cardiac Muscle Disorders: Hypertrophic and Restrictive Cardiomyopathies

  2018cites this paper
• Sudden Cardiac Death Risk Assessment

  2018cites this paper
• Correlation of left ventricular dyssynchrony on gated myocardial perfusion SPECT analysis with extent of late gadolinium enhancement on cardiac magnetic resonance imaging in hypertrophic cardiomyopathy

  2018cites this paper
• LncRNA‐MIAT regulates fibrosis in hypertrophic cardiomyopathy (HCM) by mediating the expression of miR‐29a‐3p

  2018cites this paper
• Prognostic implications of late gadolinium enhancement at the right ventricular insertion point in patients with non-ischemic dilated cardiomyopathy: A multicenter retrospective cohort study

  2018cites this paper
• Hypertrophic Cardiomyopathy in the Era of Genomic Medicine

  2018cites this paper
• Myocardial Fibrosis in Patients With Primary Mitral Regurgitation With and Without Prolapse.

  2018cites this paper
• Alterations in Myocardial Function and Electrocardiology in Hypertrophic Cardiomyopathy

  2018cites this paper
• Alcohol septal ablation in hypertrophic cardiomyopathy

  2018cites this paper
• Cardiac MRI in Diagnosis and Management

  2018cites this paper
• Cardiovascular Magnetic Resonance

  2018cites this paper
• Fragmented QRS complex in healthy adults: Prevalence, characteristics, mechanisms, and clinical implications

  2017cites this paper
• Post-mortem study of the association between cardiac iron and fibrosis in transfusion dependent anaemia

  2017cites this paper
• Prognostic Implication of the QRS Axis and its Association with Myocardial Scarring in Patients with Left Bundle Branch Block

  2017cites this paper
• Management of Ventricular Arrhtyhmias in Nonischemic Cardiomyopathic Syndromes

  2017cites this paper
• Left-ventricular mechanics in children with hypertrophic cardiomyopathy. CMR study.

  2017cites this paper